Dysplastic lesion of unknown severity of the cervix uteri

N14_CERVICAL_DYSPLASIA_NOS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N87.9 Cause of death: ICD-10 — N87.9 2 out of 7 registries used, show all original rules.	373
4. Check minimum number of events None	373
5. Include endpoints None	373
6. Filter based on genotype QC (FinnGen only)	373

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_CERVICAL_DYSPLASIA_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N879
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N879
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dysplastic lesion of unknown severity of the cervix uteri based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2302	2302	-
Only index persons	2267	2267	-
Unadjusted period prevalence (%)
Whole population	0.07	0.07	-
Only index persons	0.08	0.08	-
Median age at first event (years)
Whole population	-	39.51	-
Only index persons	-	39.34	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	373	373	-
Unadjusted period prevalence (%)	0.13	0.13	-
Median age at first event (years)	40.11	40.11	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
339: Matched controls
3389

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

+∞

323.0

339

ULA02

NOMESCO Finland

Kolposcopy

22.1

134.0

242

344

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

17.6

106.1

192

234

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

20.0

94.8

154

135

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

13.3

94.3

203

342

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

10.1

77.0

194

397

LDA10

NOMESCO Finland

Curettage of cervix uteri

12.8

59.7

115

131

N87.0

ICD-10 Finland

Mild cervical dysplasia

14.7

42.7

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

13.9

42.6

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

12.7

30.7

N87.1

ICD-10 Finland

Moderate cervical dysplasia

9.6

26.1

A63.0

ICD-10 Finland

Anogenital (venereal) warts

5.8

15.7

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.1

9.9

180

1186

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

24.8

9.0

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

92.3

8.5

LEB00

NOMESCO Finland

Biopsy of vagina

6.6

7.8

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

9.7

7.4

X86

ICPC

Abnormal cervix smear

7.6

7.3

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

17.1

6.8

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

7.6

6.5

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

5.4

6.4

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

27.2

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

118

226

7.17

63.31

2.2

1.5

—

(3025130) Human papilloma virus identified in Specimen

106

8.75

53.80

2.4

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

199

1066

2.86

22.03

2.5

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.78

3.54

1.8

2.0

13.1

13.3

0.37

(3019150) Specific gravity of Urine by Refractometry

670

1.56

3.30

3.2

1.0

kg/l

0.97

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

304

0.41

2.74

1.7

3.4

24.6

33.3

—

215

(3029937) Albumin [Presence] in Urine by Test strip

109

822

1.46

2.70

3.2

3.3

0.0

estimate

1.08

311

(3019225) pH of Specimen

229

0.38

2.64

2.8

3.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

153

1236

1.40

2.58

3.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

157

0.31

2.33

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.91

2.32

1.7

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

186

1574

1.36

2.29

3.2

3.1

0.0

estimate

0.00

304

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

272

2955

0.71

2.24

8.5

8.8

92.3

90.5

ml/min/173m2

0.75

203

2359

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

112

876

1.40

2.23

2.7

2.2

54.6

55.5

u/l

0.12

105

815

(3001019) Free T4 and TSH panel - Serum or Plasma

353

0.51

2.17

2.3

1.8

—

(4010399)

186

1.73

2.05

1.6

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.40

1.97

1.0

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

186

1599

1.33

1.96

3.2

3.1

0.0

estimate

0.50

302

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.05

1.93

4.4

9.1

—

(3013512) EKG study

654

0.66

1.87

2.0

2.9

—

(3016879) Cocaine [Presence] in Urine

181

0.43

1.87

1.3

1.5

—

(3027944) Amphetamines [Presence] in Urine

193

0.45

1.78

1.2

1.5

—

(3027008) Opiates [Presence] in Urine

193

0.45

1.78

1.2

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

193

0.45

1.78

1.2

1.5

—

(3028300) Cannabinoids [Presence] in Urine

194

0.45

1.78

1.2

1.5

—

(3017732) Neutrophils [#/volume] in Blood

236

1.58

1.73

3.4

2.4

4.4

4.0

e9/l

0.32

197

(3021601) Nitrite [Presence] in Urine by Test strip

182

1581

1.30

1.70

4.2

4.3

0.0

estimate

0.50

314

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.60

1.62

1.2

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

712

0.70

1.60

1.7

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

671

1.35

1.57

1.2

1.3

18.8

29.2

iu/ml

0.88

236

(4035726)

227

1.55

1.53

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.62

1.52

2.1

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.89

1.51

2.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

263

0.55

1.46

1.6

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

133

1.70

1.46

2.0

2.4

1.8

4.1

ug/l

2.40

118

(3002032) Base excess in Venous blood by calculation

165

1.62

1.44

4.0

3.1

2.1

2.3

mmol/l

0.16

132

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

262

0.55

1.44

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

262

0.55

1.44

1.6

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.34

1.44

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

261

0.56

1.42

1.6

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.21

1.41

7.0

1.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

127

1.69

1.40

1.1

1.2

—

(3037756) Immunofixation for Serum or Plasma

2.44

1.40

1.3

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

159

1.61

1.38

1.8

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

1.35

0.0

2.5

—

1.4

—

(40768804) Tissue Pathology biopsy report

163

1427

1.25

1.34

2.6

2.0

—

(3012544) pH of Venous blood

169

1.58

1.33

4.0

3.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.52

1.31

3.8

2.1

515.7

505.9

e6/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

278

0.59

1.30

1.6

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

124

1055

1.26

1.30

4.2

4.0

36.4

36.8

g/l

0.41

118

989

(3037522) Nuclear Ab [Titer] in Serum

520

1.33

1.24

1.4

707.5

507.1

titre

0.25

112

(3013707) Erythrocyte sedimentation rate by Westergren method

251

2319

1.25

1.23

3.7

3.8

9.8

9.5

mm/h

0.18

237

2167

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

239

1.46

1.23

1.6

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

122

1044

1.25

1.21

4.7

2.9

34.0

27.8

u/l

0.63

116

1005

(3044889) 12 lead EKG panel

216

1967

1.23

1.20

3.2

2.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.03

1.17

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

373

1.36

1.16

1.2

122.8

165.3

iu/ml

0.38

168

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

675

1.28

1.12

1.2

1.3

13.2

14.9

u/ml

0.06

279

(3003694) ABO and Rh group [Type] in Blood

1087

0.80

1.11

1.8

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.85

1.10

1.5

3.1

3.0

g/l

0.10

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

315

1.38

1.09

2.1

2.3

5.9

5.5

umol/l

0.18

268

(3009508) Creatinine [Moles/volume] in Urine

713

0.76

1.09

3.7

2.8

7.1

7.7

mmol/l

0.52

609

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

734

1.26

1.08

1.6

1.7

0.7

0.8

mg/l

0.25

550

(3018418) pH of Serum or Plasma

773

1.25

1.06

4.6

3.4

7.4

—

141

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

747

1.25

1.04

2.0

—

(3024928) Oxygen saturation in Venous blood

2.08

1.03

2.0

2.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.71

1.03

1.1

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

108

0.46

1.02

1.0

1.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

142

1256

1.21

1.01

5.3

1.2

mmol/l

0.29

124

1066

(3019230) Fractional oxyhemoglobin in Venous blood

2.19

0.98

1.8

2.0

62.4

60.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

295

1.36

0.97

1.8

2.1

1578.5

3993.1

u/l

0.85

129

(3004789) Transferrin [Mass/volume] in Serum or Plasma

350

1.32

0.94

2.4

2.1

2.5

g/l

0.33

326

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

241

2248

1.20

0.94

6.8

6.4

73.3

73.5

u/l

0.03

227

2113

(40761535) Cells panel - Urine sediment

201

1.42

0.94

3.5

2.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.74

0.93

1.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.74

0.93

1.5

1.4

7.5

7.3

g/l

0.11

(3044640) Blood type and Crossmatch panel - Blood

953

0.81

0.93

1.8

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

685

1.23

0.89

3.5

3.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

372

1.30

0.88

1.5

1.6

—

(1002224) Polysomnography panel

166

0.59

0.85

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

496

0.76

0.85

1.2

1.3

—

(3026008) Bacteria identified in Urine by Culture

102

887

1.21

0.85

2.5

2.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

180

1.42

0.84

1.8

1.7

—

(40768443) Skin Pathology biopsy report

114

0.52

0.84

1.0

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

113

1.53

0.83

1.4

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.71

0.83

1.5

10.6

9.9

g/l

0.33

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

159

1444

1.18

0.81

5.0

5.3

10.2

9.3

umol/l

0.65

148

1362

(3000991) Gas panel - Venous blood

139

1.46

0.81

6.1

7.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

222

0.66

0.80

1.7

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.77

0.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.77

0.0

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

237

1.34

0.75

1.5

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

530

1.23

0.73

1.6

1.5

436.0

43162830.0

pmol/l

1.05

468

(3024891) Influenza virus A+B Ag [Presence] in Specimen

108

0.55

0.73

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.01

0.73

1.0

—

(3015736) pH of Urine

136

1229

1.17

0.72

3.2

2.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

212

1.35

0.72

1.6

1.5

—

(3032080) INR in Blood by Coagulation assay

862

1.19

0.72

4.7

5.4

1.0

1.1

inr

2.20

288

(3047352) Trisomy 18 risk [Likelihood] in Fetus

216

0.68

0.71

1.6

1.4

—

(3005033) Fetal Nuchal fold Thickness US

214

0.69

0.68

1.6

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

107

954

1.17

0.67

2.5

2.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

307

1.26

0.64

2.8

2.3

26.8

22.8

0.93

258

(3048689) Calprotectin [Mass/mass] in Stool

473

1.22

0.64

2.4

2.1

68.1

96.1

ug/g

0.62

364

(3041354) Potassium [Moles/volume] in Venous blood

1.73

0.64

1.4

2.5

4.1

4.0

mmol/l

—

(44813793)

1.73

0.64

1.6

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

1.73

0.64

1.4

2.5

104.0

106.0

mmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.73

0.64

1.4

2.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1.73

0.64

1.0

1.1

14.8

16.7

u/l

—

(3007164) IgA [Mass/volume] in Serum or Plasma

763

0.84

0.64

1.5

1.4

2.7

2.2

g/l

1.48

491

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

235

1.30

0.63

1.5

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

656

0.83

0.62

2.2

2.1

303.0

5497.6

umol/l

2.75

598

(1761482) Bacteria [#/volume] in Urine by Culture

1.65

0.62

3.1

4.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

410

1.22

0.61

2.9

3.1

183.6

170.8

ng/l

0.03

231

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.68

0.61

1.2

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.68

0.61

1.2

1.1

—

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

0.00

0.60

0.0

1.6

—

43.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.60

0.0

2.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

0.00

0.59

0.0

1.4

—

53.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.59

0.0

1.1

—

120.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.68

0.57

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.52

0.57

1.7

2.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

159

1.34

0.56

1.3

2.5

1.2

u/ml

—

(3028707) Methadone [Presence] in Urine by Screen method

0.56

1.4

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

102

919

1.15

0.56

1.9

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.59

0.54

1.5

1.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.59

0.54

1.8

4.7

40.3

19.8

mg/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.59

0.54

1.7

4.7

62.2

30.8

mg/l

—

(3020961) Endomysium IgA Ab [Titer] in Serum

196

1.30

0.54

1.1

—

195.0

—

(4034850)

0.61

0.52

14.8

5.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.51

0.52

1.2

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.43

0.51

1.5

2.3

1.4

1.1

0.40

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

154

1.32

0.49

1.6

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

107

0.65

0.49

1.4

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

107

0.65

0.49

1.4

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

110

0.63

0.49

1.4

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

302

1.21

0.46

1.9

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

686

0.87

0.44

1.7

—

(3019060) Gas panel - Arterial blood

104

1.36

0.43

5.2

4.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

351

1.19

0.43

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.44

0.42

1.1

—

12.6

—

(3018095) Leukocytes [#/volume] in Urine

1003

0.89

0.41

4.2

3.0

74.3

59.4

e6/l

0.17

642

(4281824)

1.52

0.41

1.2

1.1

—

(3021589) Normoblasts [#/volume] in Blood

130

1390

0.90

0.41

7.7

7.4

0.0

e9/l

0.99

112

1142

(3042936) Bacteria identified in Isolate by Culture

353

1.18

0.41

1.7

2.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.41

0.0

2.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

292

0.81

0.41

1.1

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.41

0.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.41

0.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

357

3607

0.76

0.41

15.9

15.7

6.8

6.6

e9/l

0.50

350

3527

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

132

1.30

0.41

1.5

—

(3016750) Collection duration of Urine

0.00

0.40

0.0

2.4

—

517.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1022

0.89

0.40

1.6

1.7

95.5

98.9

pmol/l

0.30

547

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.34

0.40

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.48

0.40

1.2

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.40

0.0

2.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

27.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.40

0.0

1.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.42

0.39

1.3

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

160

1.26

0.39

1.5

2.1

—

(3026361) Erythrocytes [#/volume] in Blood

357

3606

0.77

0.39

15.9

15.7

4.4

e12/l

0.75

351

3532

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.39

0.0

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

292

2844

1.12

0.38

13.7

12.6

13.4

13.5

1.02

286

2805

(36660697) Celiac disease serology panel - Serum

311

0.82

0.38

1.0

1.2

—

(4062490)

1.39

0.38

1.4

—

(40761536) Microorganisms panel - Urine sediment

281

1.19

0.38

3.2

3.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

264

2718

0.90

0.37

4.8

4.4

37.6

37.9

mmol/mol

0.28

249

2576

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

191

0.78

0.37

1.1

1.8

3.2

2.5

mg/l

—

125

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

256

0.81

0.37

5.0

2.2

40.9

32.1

u/l

0.51

217

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.36

0.37

1.0

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.40

0.37

1.8

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.37

0.36

7.6

2.9

24.1

24.2

mmol/l

0.07

(4268621)

1.47

0.36

1.8

2.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

122

0.73

0.36

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

444

0.86

0.34

2.2

2.3

2.4

mmol/l

1.18

394

(3000330) Specific gravity of Urine by Test strip

127

1.27

0.34

3.1

2.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

341

3360

1.17

0.34

8.7

8.5

25.4

23.7

u/l

0.33

331

3274

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

280

2729

1.10

0.33

4.2

4.5

14.3

pmol/l

0.07

265

2570

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

305

3110

0.89

0.33

3.5

3.6

4.8

4.9

mmol/l

0.26

295

2960

(3002582) Erythrocytes [#/volume] in Urine

784

0.90

0.32

4.0

2.6

22.2

67.6

e6/l

1.25

580

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

486

1.13

0.32

1.7

1.8

—

(3022145) Colonoscopy Study observation

334

1.15

0.31

1.4

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

507

1.12

0.30

1.9

2.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

102

1.28

0.30

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

169

1762

0.93

0.29

2.9

2.8

71.9

63.1

ug/l

0.46

164

1674

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

403

1.13

0.29

3.7

2.1

0.8

0.9

e6/l

0.10

213

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

106

0.75

0.29

1.8

1.6

94.0

95.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

327

1.15

0.29

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.30

0.28

1.3

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

940

0.92

0.27

4.0

2.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.24

0.27

1.5

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

388

1.12

0.25

1.7

1.6

1248.2

1208.0

nmol/l

0.13

304

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

309

3139

0.91

0.25

3.8

3.9

2.9

mmol/l

0.22

290

2970

(3014051) Protein [Presence] in Urine by Test strip

1.22

0.25

1.6

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

767

1.09

0.25

1.7

1.3

1.4

mmol/l

0.11

674

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.74

0.24

1.2

1.5

3.2

3.6

mmol/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

106

1.23

0.23

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.32

0.23

1.6

1.7

2.5

3.5

u/ml

—

(3021788) Differential panel - Synovial fluid

1.32

0.23

1.2

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

616

0.91

0.23

4.4

3.8

9.7

7.5

mg/mmol

0.18

373

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

221

0.85

0.23

2.8

2.1

85.2

80.6

ml/min/173m2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.29

0.23

1.0

1.3

—

(3022096) Basophils/100 leukocytes in Blood

148

1422

1.07

0.23

5.9

5.3

0.7

0.06

138

1317

(3013115) Eosinophils [#/volume] in Blood

171

1651

1.07

0.23

5.5

5.7

0.2

e9/l

0.34

162

1477

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

305

3096

0.92

0.23

3.5

3.6

1.5

1.6

mmol/l

0.99

289

2938

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.76

0.22

2.4

1.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.25

0.22

2.8

2.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

225

2193

1.07

0.22

3.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.21

0.0

3.3

—

(3000012) Reticulocyte production index

0.00

0.21

0.0

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.3

—

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.21

0.0

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.21

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

0.21

0.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.21

0.0

3.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

43.4

—

(3030467) Casts [#/volume] in Urine by Automated count

715

0.92

0.21

4.4

2.4

0.4

e6/l

0.03

519

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.21

0.0

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.8

—

329.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

221

1.14

0.20

1.7

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

202

1.15

0.20

1.9

2.8

1.8

0.00

179

(4146454)

0.00

0.20

0.0

2.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.20

0.0

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

30.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

231

1.13

0.20

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.20

0.20

1.5

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

446

0.91

0.19

1.6

1.5

—

(3049717) Cytology report of Urine Cyto stain

1.18

0.19

1.5

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

569

0.92

0.19

1.4

25.2

22.1

nmol/l

0.82

495

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

227

0.87

0.18

1.1

1.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

223

1.13

0.18

4.9

5.7

104.2

104.3

mmol/l

0.03

216

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.21

0.18

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

710

0.93

0.18

2.1

2.0

2.6

2.7

mg/l

0.24

612

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.17

0.18

1.3

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

257

0.89

0.17

1.9

2.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

205

1.13

0.17

3.3

4.2

22.4

7.7

ug/l

0.50

163

(3004716) Salmonella sp identified in Stool by Organism specific culture

236

0.88

0.17

2.1

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.11

0.17

1.9

3.2

4.0

4.5

e9/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

141

0.85

0.16

1.4

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.15

0.16

1.1

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

308

3114

0.94

0.15

4.8

5.1

1.7

2.1

mu/l

0.55

291

2955

(42870588) Differential panel, method unspecified - Blood

968

0.95

0.15

5.6

5.2

—

(3022621) pH of Urine by Test strip

198

1.12

0.14

1.7

2.3

—

(3008898) HLA-B27 [Presence]

198

1.12

0.14

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

913

1.05

0.14

2.3

2.8

112.6

17.5

ng/l

0.51

428

(46235355) HIV 1 and 2 tests - Meaningful Use set

1006

0.95

0.13

2.1

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

834

0.95

0.13

3.0

4.0

—

(1761868) Lipid panel - Serum or Plasma

127

1308

0.96

0.13

2.2

2.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

158

1541

1.04

0.13

3.9

3.8

—

(3018010) Neutrophils/100 leukocytes in Blood

149

1527

0.96

0.12

5.5

5.1

55.0

56.5

0.92

140

1429

(3006315) Basophils [#/volume] in Blood

155

1586

0.96

0.12

5.3

0.0

e9/l

0.73

140

1392

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

404

0.93

0.11

1.3

1.5

—

(36304419) Bacteria [Presence] in Urine

729

0.95

0.11

4.2

2.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

177

1804

0.96

0.11

7.6

8.4

4.0

3.9

e9/l

0.20

163

1589

(3012516) Albumin [Mass/volume] in Urine

594

0.95

0.10

3.8

3.1

60.0

286.5

mg/l

0.70

368

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.11

0.10

1.2

1.4

—

(3001604) Monocytes [#/volume] in Blood

155

1580

0.97

0.09

5.3

0.5

e9/l

0.25

142

1391

(3009542) Hematocrit [Volume Fraction] of Blood

311

3087

1.04

0.09

12.9

11.3

39.5

39.6

0.10

249

2545

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.11

0.09

2.2

2.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.11

0.09

1.2

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.07

0.08

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

175

0.91

0.08

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

113

1104

1.03

0.08

5.3

4.7

1.2

mmol/l

0.17

104

1018

(3014007) Fractional oxyhemoglobin in Arterial blood

107

1.13

0.08

6.2

7.7

90.4

94.4

0.64

107

(3000494) Fungus identified in Specimen by Culture

338

0.94

0.08

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.83

0.08

1.4

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.78

0.08

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.77

0.08

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.10

0.08

1.9

3.8

59.1

58.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

123

0.89

0.08

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.05

0.08

1.1

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

0.85

0.07

1.0

1.6

—

(40768797) Stomach Pathology biopsy report

387

0.95

0.07

1.1

1.2

—

(40758558) Short blood count panel - Blood

780

1.03

0.07

6.0

6.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.84

0.06

2.3

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

193

0.93

0.06

1.9

1.3

266.1

253.5

miu/ml

—

101

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

103

0.87

0.06

1.0

1.5

17.3

22.9

u/l

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

310

3118

0.97

0.06

10.9

10.2

3.9

mmol/l

0.19

302

3016

(3045414) Leukocytes [Presence] in Urine

148

1.08

0.06

1.4

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

672

1.03

0.06

1.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

309

3107

0.97

0.06

10.9

10.1

139.4

139.6

mmol/l

0.83

301

3017

(3000850) Epithelial cells [#/volume] in Urine

544

1.03

0.05

3.2

2.3

11.6

9.6

e6/l

0.17

473

(3002030) Lymphocytes/100 leukocytes in Blood

152

1540

0.98

0.05

5.6

5.3

31.0

29.7

0.94

144

1434

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

475

1.04

0.05

1.7

2.8

313.6

653.0

ng/l

2.14

390

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

131

1327

0.98

0.04

2.2

74.9

75.4

nmol/l

0.06

121

1227

(3000492) Spirometry study

298

1.04

0.04

1.7

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

487

1.03

0.04

2.0

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

378

1.04

0.04

3.5

2.2

3.9

4.4

e6/l

0.13

188

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

121

1.08

0.04

1.3

—

(40761511) CBC panel - Blood by Automated count

340

3411

0.96

0.03

10.3

9.7

—

(3019069) Monocytes/100 leukocytes in Blood

150

1485

1.02

0.03

6.0

5.4

8.2

7.9

0.47

141

1390

(3013826) Glucose [Moles/volume] in Serum or Plasma

161

1595

1.02

0.03

3.6

3.8

6.3

mmol/l

0.01

144

1435

(3019198) Lymphocytes [#/volume] in Blood

162

1635

0.98

0.03

5.6

5.3

2.0

e9/l

0.27

151

1465

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

518

1.03

0.03

1.5

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

322

3208

1.03

0.03

10.9

10.3

22.6

18.5

mg/l

1.17

246

2431

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

240

1.04

0.03

1.2

—

21.5

—

(3026782) Osmolality of Urine

499

1.03

0.03

3.3

2.3

523.2

536.3

mosm/kgh2o

0.17

419

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

122

1.07

0.02

2.7

2.2

—

(3023368) Bacteria identified in Blood by Culture

559

0.98

0.02

3.5

3.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

302

1.03

0.02

1.7

2.0

378.6

373.6

nmol/l

0.05

284

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

296

2968

0.99

0.01

3.0

3.3

1.2

mmol/l

0.29

280

2808

(3006504) Eosinophils/100 leukocytes in Blood

149

1482

1.01

0.01

5.5

5.2

2.9

2.7

0.66

139

1378

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

853

1.01

0.01

1.9

1.7

—

(3002256) Pathology report gross observation

414

1.02

0.00

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

298

2986

0.99

0.00

3.4

3.6

5.6

mmol/l

0.08

277

2797

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

227

2276

0.99

0.00

2.8

41.8

33.6

u/l

0.80

217

2183

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

109

1.01

0.00

1.7

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

221

1.00

0.00

9.0

12.1

—

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

889

1.00

0.00

1.2

1.3

0.7

2.1

u/ml

1.53

257

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

143

0.98

0.00

1.8

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

153

0.98

0.00

10.1

6.8

9.4

7.2

mmol/l

0.52

146

(3050129) First trimester maternal screen panel - Serum or Plasma

297

1.01

0.00

1.4

1.5

—

(3025941) Bacteria identified in Stool by Culture

205

1.03

0.00

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

305

1.02

0.00

7.1

4.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

265

2645

1.01

0.00

3.6

3.9

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

3.3

—

45.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.0

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.0

1.7

—

132.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.5

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

2.0

—

(3018133) Calcium [Moles/volume] in Urine

0.00

0.0

1.7

—

3.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

2.0

—

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.85

0.00

8.0

3.5

3.4

3.7

mmol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.0

1.9

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.85

0.00

1.4

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

0.0

1.1

—

145.4

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

11.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

2.8

—

(3035880) pH of Pleural fluid

0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.00

0.0

1.1

—

441.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.0

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(44806071)

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.0

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.0

1.2

—

15.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.0

1.3

—

(3014271) Vancomycin [Susceptibility]

0.00

0.0

1.9

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(4306422)

0.98

0.00

2.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

6.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.0

8.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

170

1.00

0.00

4.2

5.5

1.2

mmol/l

0.07

165

(3020891) Body temperature

0.87

0.00

7.3

4.2

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

0.91

0.00

15.0

3.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.92

0.00

1.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.3

—

(3017569) Oxygen content in Arterial blood

0.00

0.0

4.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.2

—

(4133840)

0.00

0.0

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.00

0.0

1.3

—

41.1

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.4

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.0

2.6

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

0.0

2.0

—

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_CERVICAL_DYSPLASIA_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_CERVICAL_DYSPLASIA_NOS	1.369 [1.07, 1.75]	0.012
Birth year	0.993 [0.98, 1.0]	0.115

During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 1959 females with N14_CERVICAL_DYSPLASIA_NOS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_CERVICAL_DYSPLASIA_NOS.

N-year risk	Females	Males
1	0.13%	No data
5	0.761%	No data
10	1.873%	No data
15	3.773%	No data
20	6.533%	No data

Relationships between endpoints

↥

Index endpoint: N14_CERVICAL_DYSPLASIA_NOS – Dysplastic lesion of unknown severity of the cervix uteri

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dysplastic lesion of unknown severity of the cervix uteri

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints